As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/3/24  Enveric Biosciences, Inc.         424B5                  1:503K                                   M2 Compliance LLC/FA     
  5/3/24  Enveric Biosciences, Inc.         8-K:1,9      5/3/24   12:409K                                   M2 Compliance LLC/FA     
 4/16/24  Enveric Biosciences, Inc.         ARS        12/31/23    1:11M                                    M2 Compliance LLC/FA     
 4/16/24  Enveric Biosciences, Inc.         DEF 14A     4/16/24    1:1.5M                                   M2 Compliance LLC/FA     
 3/28/24  Enveric Biosciences, Inc.         8-K:5       3/27/24   10:197K                                   M2 Compliance LLC/FA     
 3/26/24  Enveric Biosciences, Inc.         8-K:2,9     3/26/24   11:247K                                   M2 Compliance LLC/FA     
 3/26/24‡ Enveric Biosciences, Inc.         10-K       12/31/23   84:9.2M                                   M2 Compliance LLC/FA     
 3/19/24  Enveric Biosciences, Inc.         8-K:7,9     3/19/24   11:260K                                   M2 Compliance LLC/FA     
 3/11/24  Enveric Biosciences, Inc.         424B5                  1:489K                                   M2 Compliance LLC/FA     
 3/11/24  Enveric Biosciences, Inc.         8-K:1,9      3/8/24   12:463K                                   M2 Compliance LLC/FA     
 2/29/24  Enveric Biosciences, Inc.         8-K:7,9     2/29/24   11:234K                                   M2 Compliance LLC/FA     
 2/26/24  Tucker Joseph Edward              4          Dir.,Off.²  1:5K   Enveric Biosciences, Inc.         SEC Connect              
 2/26/24  Facchini Peter J.                 4          Officer²    1:5K   Enveric Biosciences, Inc.         SEC Connect              
 2/26/24  Coveney Kevin Michael             4          Officer²    1:5K   Enveric Biosciences, Inc.         SEC Connect              
 2/21/24  Enveric Biosciences, Inc.         8-K:7,9     2/21/24   11:259K                                   M2 Compliance LLC/FA     
 2/14/24  Armistice Capital, LLC            SC 13G                 1:88K  Enveric Biosciences, Inc.         Adviser Compliance … LLC 
  2/9/24  Enveric Biosciences, Inc.         8-K:3        2/6/24   10:200K                                   M2 Compliance LLC/FA     
  2/6/24  Intracoastal Capital, LLC         SC 13G/A               1:76K  Enveric Biosciences, Inc.         EdgarAgents LLC/FA       
          Daniel B. Asher³
          Mitchell P. Kopin³
  2/5/24  Hudson Bay Capital Management LP  SC 13G/A               1:54K  Enveric Biosciences, Inc.                                  
 1/24/24  Enveric Biosciences, Inc.         424B3                  1:181K                                   M2 Compliance LLC/FA     

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	424B3	Prospectus – New Facts or Events.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.